My name is Meg Snyder, and I am excited to be the new editor of Pharmaceutical Processing. I am a journalist and a medical writer, with a background in news features. I have written on varying disease states for a variety of medical specialties, which can be found in Rheumatology News, OBG Management, Neurology Reviews, and a number of other publications. These disease states include, but are not limited to, conditions such as multiple sclerosis, rheumatoid arthritis, epilepsy, endometriosis, Parkinson disease and diabetes.

I have become intimately acquainted with the unique signatures of different genres of writing, as well as the prominence of creativity interwoven throughout as both readers and writers seek knowledge and understanding. I believe that the pursuit of excellence is a universal standard amongst all readers, regardless of their field. One of my primary goals in this new position is to facilitate a platform where professionals can come together to share their experiences, ideas, and perhaps even some healthy banter.  

I find that I have not only a deep love of learning, but also a knack for asking tactical questions and delving into multifaceted topics and discussions. I am excited to join the Pharmaceutical Processing team, and look forward to learning even more about our industry.

In the October 2015 edition of Pharmaceutical Processing, one of the things we talk about is biosimilars (as well as generics, botanical medicines, and a number of other topics). Although we have heard much on the subject of biosimilars in recent years, the first was approved in the United States only this year. Given the emergence of this new form of medication (particularly on my home turf), I am eager to learn more about this new development and see where it takes us as an industry.

Finally, please let us know how we are doing. If there are any specific topics you would like to see in one of our upcoming issues or on www.pharmpro.com, let me know! Thanks for reading and I look forward to continuing in the fine traditions of your leading source for news, product information and the latest trends impacting pharmaceutical production.

Want to read more? Check out our October 2015 edition.